Pure Global
NCT05842811

An Observational Study of Patients With Metabolic Syndrome and Related Conditions

Target PharmaSolutions, Inc.·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Metabolic Syndrome
Study type
Observational
Sponsor & location
Primary sponsor
Target PharmaSolutions, Inc.
Timeline & enrollment
Phase
N/A
Start date
May 24, 2023
End date
Dec 31, 2038
Enrollment
2000000 participants
Primary outcome

To characterize the natural history of disease in patients with metabolic syndrome and related conditions,To assess safety and effectiveness of treatments for metabolic syndrome and related conditions.

Summary

TARGET-METABOLIC is an observational research study to conduct a comprehensive review of
 outcomes for patients with metabolic syndrome and related conditions.

ICD-10 classifications
Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05842811
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05842811 through Pure Global AI's free database. This phase not specified trial is sponsored by Target PharmaSolutions, Inc. and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 2000000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.